Jessica J. Hawes - Publications

Affiliations: 
NCI, Somers, CT, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Gürsel DB, Connell-Albert YS, Tuskan RG, Anastassiadis T, Walrath JC, Hawes JJ, Amlin-Van Schaick JC, Reilly KM. Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies. Neuro-Oncology. 13: 610-21. PMID 21636709 DOI: 10.1093/neuonc/nor035  1
2010 Walrath JC, Hawes JJ, Van Dyke T, Reilly KM. Genetically engineered mouse models in cancer research. Advances in Cancer Research. 106: 113-64. PMID 20399958 DOI: 10.1016/S0065-230X(10)06004-5  1
2010 Hawes JJ, Reilly KM. Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis. Toxicologic Pathology. 38: 123-30. PMID 20176786 DOI: 10.1177/0192623309357075  1
2008 Hawes JJ, Nerva JD, Reilly KM. Novel dual-reporter preclinical screen for antiastrocytoma agents identifies cytostatic and cytotoxic compounds. Journal of Biomolecular Screening. 13: 795-803. PMID 18664715 DOI: 10.1177/1087057108321085  1
2008 Hawes JJ, Brunzell DH, Narasimhaiah R, Langel U, Wynick D, Picciotto MR. Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1864-73. PMID 17957220 DOI: 10.1038/sj.npp.1301579  1
2007 Hawes JJ, Tuskan RG, Reilly KM. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics. 8: 121-30. PMID 17216419 DOI: 10.1007/s10048-006-0078-5  1
2006 Hawes JJ, Narasimhaiah R, Picciotto MR. Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal-related kinase. The European Journal of Neuroscience. 23: 2937-46. PMID 16819983 DOI: 10.1111/j.1460-9568.2006.04828.x  1
2006 Hawes JJ, Narasimhaiah R, Picciotto MR. Galanin attenuates cyclic AMP regulatory element-binding protein (CREB) phosphorylation induced by chronic morphine and naloxone challenge in Cath.a cells and primary striatal cultures. Journal of Neurochemistry. 96: 1160-8. PMID 16417577 DOI: 10.1111/j.1471-4159.2005.03613.x  1
2005 Picciotto MR, Hawes JJ, Brunzell DH, Zachariou V. Galanin can attenuate opiate reinforcement and withdrawal. Neuropeptides. 39: 313-5. PMID 15944028 DOI: 10.1016/j.npep.2004.12.001  1
2005 Hawes JJ, Brunzell DH, Wynick D, Zachariou V, Picciotto MR. GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism. Journal of Neurochemistry. 93: 1168-76. PMID 15934937 DOI: 10.1111/j.1471-4159.2005.03105.x  1
2004 Hawes JJ, Picciotto MR. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. The Journal of Comparative Neurology. 479: 410-23. PMID 15514977 DOI: 10.1002/cne.20329  1
2003 Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR. The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 100: 9028-33. PMID 12853567 DOI: 10.1073/pnas.1533224100  1
Show low-probability matches.